A prominent Indian life sciences research and development company is preparing to execute a notable block deal involving an equity stake reduction. Investors and market watchers are closely observing this development, which involves the promoter group divesting approximately 2% of its shareholding. The upcoming block deal is estimated at around Rs. 660 crore. Share Price … Continue reading Pharma stock in focus after promoter sells stake worth ₹706 Cr in the company